Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HETERO LABS LTD V

  • FDA Approval
  • Sept. 18, 2024, 08:40 UTC
  • 19
  • 0 comments

FDA approve SIROLIMUS

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Sept. 18, 2024, 08:40 UTC
  • 20
  • 0 comments

FDA approve SACUBITRIL; VALSARTAN

Comment Full text

NATCO PHARMA LTD

  • FDA Approval
  • Sept. 18, 2024, 08:40 UTC
  • 20
  • 0 comments

FDA approve BOSENTAN

Comment Full text

BAUSCH

  • FDA Approval
  • Sept. 17, 2024, 18:28 UTC
  • 27
  • 0 comments

FDA approve IMIQUIMOD

Comment Full text

RECORDATI RARE

  • FDA Approval
  • Sept. 17, 2024, 18:28 UTC
  • 26
  • 0 comments

FDA approve SUCCIMER

Comment Full text

CUMBERLAND

  • FDA Approval
  • Sept. 17, 2024, 18:28 UTC
  • 23
  • 0 comments

FDA approve GRANISETRON

Comment Full text

CHIA TAI TIANQING

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 22
  • 0 comments

FDA approve FOSAPREPITANT DIMEGLUMINE

Comment Full text

MSN

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 21
  • 0 comments

FDA approve NELARABINE

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 16
  • 0 comments

FDA approve ERLOTINIB HYDROCHLORIDE

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 21
  • 0 comments

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text
  • Previous
  • 260
  • 261
  • 262
  • 263
  • 264
  • Next

Search

News categories

  • Technical Exchange News(9977)
  • Event(412)
  • SEC News(168776)
  • FDA Approval(9377)
  • Company Report(721)
  • Business News(112391)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin